These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20135693)

  • 21. Development of cup shaped microneedle array for transdermal drug delivery.
    Vinayakumar KB; Hegde GM; Ramachandra SG; Nayak MM; Dinesh NS; Rajanna K
    Biointerphases; 2015 Jun; 10(2):021008. PubMed ID: 25956180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cold Flow Evaluation in Transdermal Drug Delivery Systems by Measuring the Width of the Oozed Adhesive.
    Miyazaki T; Kanno H; Yamamoto E; Ando D; Izutsu KI; Goda Y
    AAPS PharmSciTech; 2020 Apr; 21(4):120. PubMed ID: 32323091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel transdermal drug delivery system based on self-adhesive Janus nanofibrous film with high breathability and monodirectional water-penetration.
    Shi Y; Li Y; Wu J; Wang W; Dong A; Zhang J
    J Biomater Sci Polym Ed; 2014; 25(7):713-28. PubMed ID: 24641249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delivering drugs by the transdermal route: review and comment.
    Tanner T; Marks R
    Skin Res Technol; 2008 Aug; 14(3):249-60. PubMed ID: 19159369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-layer weekly sustained release transdermal patch containing gestodene and ethinylestradiol.
    Gao Y; Liang J; Liu J; Xiao Y
    Int J Pharm; 2009 Jul; 377(1-2):128-34. PubMed ID: 19463930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transdermal patches: Design and current approaches to painless drug delivery.
    Al Hanbali OA; Khan HMS; Sarfraz M; Arafat M; Ijaz S; Hameed A
    Acta Pharm; 2019 Jun; 69(2):197-215. PubMed ID: 31259729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can biologically inspired patches yield a new age of transdermal delivery?
    Chang CC
    Ther Deliv; 2014 Apr; 5(4):373-5. PubMed ID: 24856163
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparison of Adhesive Properties of Transdermal Patches Distributing in Japan-Tack and Peel Strength].
    Miyazaki T; Kanno H; Aso Y; Goda Y
    Yakugaku Zasshi; 2018 Nov; 138(11):1425-1433. PubMed ID: 30146539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of adhesive properties of patches based on acrylic matrices.
    Minghetti P; Cilurzo F; Montanari L
    Drug Dev Ind Pharm; 1999 Jan; 25(1):1-6. PubMed ID: 10028412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current advances in the fabrication of microneedles for transdermal delivery.
    Indermun S; Luttge R; Choonara YE; Kumar P; du Toit LC; Modi G; Pillay V
    J Control Release; 2014 Jul; 185():130-8. PubMed ID: 24806483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of adhesive properties of transdermal therapeutic systems containing nitroglycerin.
    Minghetti P; Casiraghi A; Cilurzo F; Montanari L
    Boll Chim Farm; 2001; 140(2):63-7. PubMed ID: 11417388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical attributes of transdermal drug delivery system (TDDS)--a generic product development review.
    Ruby PK; Pathak SM; Aggarwal D
    Drug Dev Ind Pharm; 2014 Nov; 40(11):1421-8. PubMed ID: 24467407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solid-State Stability Issues of Drugs in Transdermal Patch Formulations.
    Sharma PK; Panda A; Pradhan A; Zhang J; Thakkar R; Whang CH; Repka MA; Murthy SN
    AAPS PharmSciTech; 2018 Jan; 19(1):27-35. PubMed ID: 28895101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microneedles for transdermal drug delivery.
    Prausnitz MR
    Adv Drug Deliv Rev; 2004 Mar; 56(5):581-7. PubMed ID: 15019747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AC electrokinetic platform for iontophoretic transdermal drug delivery.
    Lvovich VF; Matthews E; Riga AT; Kaza L
    J Control Release; 2010 Jul; 145(2):134-40. PubMed ID: 20420867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A commentary on transdermal drug delivery systems in clinical trials.
    Watkinson AC
    J Pharm Sci; 2013 Sep; 102(9):3082-8. PubMed ID: 23468246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adhesive backing foil interactions affecting the elasticity, adhesion strength of laminates, and how to interpret these properties of branded transdermal patches.
    Fauth C; Wiedersberg S; Neubert RH; Dittgen M
    Drug Dev Ind Pharm; 2002 Nov; 28(10):1251-9. PubMed ID: 12476871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro release of fentanyl from transdermal patches in gastric and intestinal fluid.
    Arroyo Plasencia AM; Mowry J; Smith J; Quigley K
    Clin Toxicol (Phila); 2014 Nov; 52(9):945-7. PubMed ID: 25345435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transdermal drug delivery devices for chronotherapy.
    Hradetzky D
    Med Device Technol; 2008; 19(3):45-7. PubMed ID: 18557410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular effects of transdermally delivered bupranolol in rabbits: effect of chemical penetration enhancers.
    Babu RJ; Dhanasekaran M; Vaithiyalingam SR; Singh PN; Pandit JK
    Life Sci; 2008 Jan; 82(5-6):273-8. PubMed ID: 18096189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.